Clinical Trials in San Francisco

Showing 8741-8760 of 12,991 trials

Cross-linking of Corneal Collagen (CXL) With Ultraviolet-A in Asymmetric Corneas

NCT01189864

The purpose of this study is to evaluate the efficacy of ultraviolet-A (UVA)-induced cross-linking of corneal collagen (CXL) as a method to increase the biomechanical and biochemical stability of the cornea by inducing additional cross-links within or between collagen fibers using UVA light and the photo- mediator riboflavin. The purpose of this study is to generate data for presentation at medical meetings and for peer-review publication. The data generated by this study will not be submitted to the FDA to support commercialization of these riboflavin drops.

KeratoconusEctasiaDegeneration

Cxlusa3,493 participantsStarted Feb 2010

Scottsdale, Arizona, United States • Laguna Hills, California, United States • San Diego, California, United States +13 more locations

COMPLETEDPhase 3< 1 mile

Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults

NCT00118898

Currently, the preferred anti-HIV regimens used in the United States consist of two nucleoside reverse transcriptase inhibitors (NRTIs) and the nonnucleoside reverse transcriptase inhibitor (NNRTI) efavirenz (EFV). However, with new anti-HIV drugs being approved, alternative regimens need to be tested to determine if new drug combinations have increased effectiveness in treating HIV. The purpose of this study is to test the safety, tolerability, and effectiveness of four different regimens in HIV-infected adults who have never taken anti-HIV drugs.

HIV Infections

Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections1,864 participantsStarted Sep 2005

Los Angeles, California, United States • Los Angeles, California, United States • Palo Alto, California, United States +49 more locations

Cross-linking of Corneal Collagen (CXL) With Ultraviolet-A in Asymmetric Corneas

Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults

Find Trials by Condition in San Francisco

Pioglitazone Before Peginterferon and Ribavirin for Hepatitis C Infection in HIV/HCV-Coinfected Patients With Insulin Resistance

Genetics Study of Wet Age-Related Macular Degeneration (AMD) Non-Responders to Vascular Endothelial Growth Factor (VEGF) Therapy

Virtual Intervention for Lung Cancer

Sevelamer for Reducing Endotoxemia and Immune Activation

Getting in Balance: A Workplace Diabetes Prevention Intervention Trial

Substance Abuse Treatment to HIV Care (SAT2HIV): The Implementation & Sustainment Facilitation Experiment

A Study of Axitinib in Advanced Carcinoid Tumors

CalFitness Smartphone-Delivered Physical Activity Intervention

Post-Market Study of the Modular Revision Hip System

Clinical Trial of the Senza™ SCS System in the Treatment of Chronic Upper Limb and Neck Pain

A Study Comparing the Efficacy, Safety and Tolerability of Fixed Dose Combination (FDC) of FF/UMEC/VI With the FDC of FF/VI and UMEC/VI; Administered Once-daily Via a Dry Powder Inhaler (DPI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Light Treatment for Sleep/Wake Disturbances in Alzheimer's Disease

Multicenter Continuous Peripheral Nerve Block Surveillance Study

A Safety and Efficacy Study of LiRIS® in Females With Interstitial Cystitis With Hunner's Lesions

A Study of the Blood Pressure Lowering Ability and Safety of Olmesartan Medoxomil in Stage I and Stage II Hypertension

Prospective Evaluation of Anti-retroviral Combinations for Treatment Naive, HIV Infected Persons in Resource-limited Settings

Safety, Efficacy, Dose-finding Study of a Monoclonal Antibody in Patients With Multiple Myeloma

Safety and Efficacy of Buparlisib (BKM120) in Patients With Untreated Squamous Non-small Cell Lung Cancer